Muscular Dystrophy is a rare genetic disorder causing progressive muscle weakness and degeneration, affecting about1 in 3,500 male births worldwide.

Boy Overcomes Muscular Dystrophy Disorder to Pursue Studies at the Prestigious Indian Institute of Technology (IIT)

MUMBAI, 30 JUNE, 2023 (GPN/ BABITA PM)– StemRx BioScience Solutions India, under the guidance of Dr. Pradeep Mahajan, a renowned Regenerative Medicine Researcher, has achieved a remarkable milestone in the treatment of Duchenne Muscular Dystrophy (DMD). A 21-year-old boy from Bihar, who had been suffering from rare DMD from past 10 years, is now able to stand and walk independently for the first time in a decade, thanks to an innovative cell-based therapy.

Muscular Dystrophy is a rare genetic disorder characterized by progressive muscle weakness and degeneration affecting approximately 1 in 3,500 male births worldwide. It primarily affects boys and is caused by a mutation in the dystrophin gene responsible for producing a vital muscle protein. The absence of this protein leads to muscle deterioration and loss of functionality. Patients with DMD face significant challenges in mobility and performing daily activities.

Vipul Indresh, had been unable to walk since early childhood and stared facing difficulties in 2014. Upon diagnosis with DMD, his parents embarked on a journey to explore various treatment options. Despite trying medications and alternative therapies, his condition continued to worsen. Seeking a breakthrough solution in 2015, they decided to bring Vipul to Navi Mumbai, StemRx Bioscience for treatment under the care of Dr. Pradeep Mahajan.

Dr. Pradeep Mahajan, a leading expert in Regenerative Medicine, recommended a cutting-edge cell-based therapy for Vipul. The treatment involves using stem cells capable of differentiating into muscle cells to regenerate and replace the damaged muscle fibers caused by DMD. Following the therapy for around 6 months, Vipul’s muscles started to strengthen, and he regained his ability to walk independently. The transformative results have not only improved his physical capabilities but have also opened doors for him to pursue his studies at the prestigious Indian Institute of Technology (IIT).

Speaking on the potential of cell-based therapy for DMD, Dr. Pradeep Mahajan expressed his optimism, “Cellular therapy offers hope for individuals with Duchenne Muscular Dystrophy by addressing the root cause of the disease. The transplanted stem cells have the ability to regenerate and replace damaged muscle fibers, leading to improved muscle function and quality of life. Moreover, this innovative therapy may have anti-inflammatory properties, which can help combat the chronic inflammation associated with DMD and slow down disease progression.”

Vikram Indresh, Vipul’s father, expressed his gratitude for the transformational treatment, stating, “Since childhood, our son faced the challenges of Duchenne Muscular Dystrophy, which deprived him of the ability to walk. After exploring various options, we entrusted Dr. Pradeep Mahajan and his team at StemRx BioScience Solutions, Mumbai, India. The cell-based therapy they recommended has given a new lease of life to our son, strengthening his muscles and enabling him to walk again. We are immensely grateful to the doctors for this remarkable achievement.”

The breakthrough achieved by Dr. Pradeep Mahajan and his team at StemRx BioScience Solutions India brings hope to the DMD community and highlights the potential of cell-based therapies in treating this debilitating genetic disease. Continued research and advancements in regenerative medicine offer the prospect of improved outcomes and enhanced quality of life for individuals affected by DMD.

###